Latest Breaking News On - Scientific session - Page 1 : vimarsana.com

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United statesFederico aschRicharde kerberLloyd huckLinda gillamArthure weyman youngJulius gardinEric kruseBenjamin eidemJagat narulaRichard kerberHarvey feigenbaumStephen littlePath to health equityWorld heart federationMedstar health

Novel PCSK9 Inhibitor Reduced LDL by 50%

Lerodalcibep, a third-generation PCSK9 inhibitor, reduced LDL by more than 50% vs placebo in patients with or at a high risk for CVD in the phase 3 LIBerate-HR trial.

South africaUnited statesEric klugAmerican college of cardiologyDivision of cardiologyUniversity of the witwatersrandEuropean society of cardiologyPrevention of cardiovascular disease councilVirginia commonwealth university school of pharmacyAmerican heart associationDrug administrationAmerican collegeScientific sessionEuropean societyVirginia commonwealth university schoolCardiovascular disease council

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.

Czech republicUnited statesTtirzepatide zepboundEli lillyJeff emmickNational council onAmerican diabetes associationObstructive sleep apnea master protocolParticipants with obstructive sleepScientific sessionNational councilApnea statisticsFacts you should

Complete Revasc Not Superior to Culprit-Only PCI After MI

In patients with STEMI and multivessel disease, FFR-guided complete nonculprit revascularization did not reduce events vs culprit lesion-only PCI in the FULL-REVASC trial.

United statesNewcastle upon tyneUnited kingdomStanford universityVijay kunadianWilliam fearonStanford university school of medicineNewcastle universityCardiothoracic centreGroup efficacyKarolinska instituteAmerican college of cardiologyDanderyd hospitalAmerican collegeScientific sessionNew england journal

Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity

The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury.

New yorkUnited statesDavid austinAnita deswalAmerican college of cardiologyNational health serviceUniversity of texasJames cook university hospitalDepartment of cardiologyDivision of internal medicineIcahn school of medicine at mount sinaiAcademic cardiovascular unitAmerican collegeScientific sessionInternal medicineMedscape cardiology